Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Management of post-autologous transplant relapse in patients with T-cell lymphomas.
Veilleux O, Socola F, Arai S, Frank MJ, Johnston L, Lowsky R, Shizuru J, Meyer E, Muffly L, Rezvani AR, Shiraz P, Sidana S, Dahiya S, Miklos DB, Negrin RS, Weng WK. Veilleux O, et al. Among authors: shizuru j. Am J Hematol. 2024 Aug;99(8):1485-1491. doi: 10.1002/ajh.27345. Epub 2024 Apr 25. Am J Hematol. 2024. PMID: 38661220
Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: no improvement in outcomes compared with single-course high-dose therapy.
Hu WW, Negrin RS, Stockerl-Goldstein K, Johnston LJ, Shizuru JA, Wong RM, Chao NJ, Long GD, Feiner RH, Blume KG. Hu WW, et al. Among authors: shizuru ja. Biol Blood Marrow Transplant. 2000;6(1):58-69. doi: 10.1016/s1083-8791(00)70053-x. Biol Blood Marrow Transplant. 2000. PMID: 10708000 Free article.
Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation.
Cao TM, Negrin RS, Stockerl-Goldstein KE, Johnston LJ, Shizuru JA, Taylor TL, Rizk NW, Wong RM, Blume KG, Hu WW. Cao TM, et al. Among authors: shizuru ja. Biol Blood Marrow Transplant. 2000;6(4):387-94. doi: 10.1016/s1083-8791(00)70015-2. Biol Blood Marrow Transplant. 2000. PMID: 10917574 Free article.
High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experience.
Cao TM, Horning S, Negrin RS, Hu WW, Johnston LJ, Taylor TL, Shizuru JA, Hoppe RT, Brown BW, Blume KG, Stockerl-Goldstein KE. Cao TM, et al. Among authors: shizuru ja. Biol Blood Marrow Transplant. 2001;7(5):294-301. doi: 10.1053/bbmt.2001.v7.pm11400952. Biol Blood Marrow Transplant. 2001. PMID: 11400952 Free article.
Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease.
Stuart MJ, Chao NS, Horning SJ, Wong RM, Negrin RS, Johnston LJ, Shizuru JA, Long GD, Blume KG, Stockerl-Goldstein KE. Stuart MJ, et al. Among authors: shizuru ja. Biol Blood Marrow Transplant. 2001;7(10):552-60. doi: 10.1016/s1083-8791(01)70015-8. Biol Blood Marrow Transplant. 2001. PMID: 11760087 Free article. Clinical Trial.
169 results